Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Assets (2016 - 2025)

Historic Assets for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $3.5 billion.

  • Prestige Consumer Healthcare's Assets rose 496.31% to $3.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.5 billion, marking a year-over-year increase of 496.31%. This contributed to the annual value of $3.4 billion for FY2025, which is 252.53% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Assets of $3.5 billion as of Q4 2025, which was up 496.31% from $3.4 billion recorded in Q3 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Assets peaked at $3.7 billion during Q4 2022, and registered a low of $3.3 billion during Q2 2024.
  • For the 5-year period, Prestige Consumer Healthcare's Assets averaged around $3.5 billion, with its median value being $3.4 billion (2021).
  • In the last 5 years, Prestige Consumer Healthcare's Assets soared by 703.96% in 2022 and then tumbled by 1093.46% in 2023.
  • Over the past 5 years, Prestige Consumer Healthcare's Assets (Quarter) stood at $3.7 billion in 2021, then rose by 2.47% to $3.7 billion in 2022, then dropped by 10.93% to $3.3 billion in 2023, then decreased by 0.31% to $3.3 billion in 2024, then grew by 4.96% to $3.5 billion in 2025.
  • Its Assets was $3.5 billion in Q4 2025, compared to $3.4 billion in Q3 2025 and $3.4 billion in Q2 2025.